Regulatory Updates
🇺🇸 FDA Page 5FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 49–60 of 382 articles
Summit Pipeline Approvals and Competitive Outlook: 2023-2024 Update
6 min
Dr. Sarah MitchellListeria Outbreaks 2026: FDA and CDC Soft Cheese Recall Analysis for Pharma
FDA · oncology · 6 min
Dr. Sarah Mitchell5 Notable Oncology FDA Approvals Granted in May: A B2B Analysis
FDA · oncology · 6 min
Dr. Sarah MitchellWeekly Buzz: PHG, KMDA Win FDA Nod; FULC Halts Pociredir; RMD Closes Noctrix Deal; NVS Paces In IgAN
FDA · IgAN · 6 min
Dr. Sarah MitchellThe FDA Amendments Act And Drug Safety: Twenty Years Later
FDA · 5 min
Dr. Sarah MitchellFDA Issues June 2026 Guidance: Gene Therapy, Payor Comms, and CMC Flexibilities
FDA · 4 min
Dr. Sarah MitchellFriday Five: ASCO Takeaways, ADA Focus, China Deals & More – Clinical Trials
4 min
Dr. Sarah MitchellMay 2026 FDA Oncology Actions: 8 Approvals Reshape the Landscape
FDA · oncology · 5 min
Dr. Sarah MitchellFDA clears U.S. trial of MAIA lung cancer drug for third-line patients
FDA · lung cancer · 6 min
Dr. Sarah MitchellPharma bets on PD-1/VEGF bispecifics: Is lung cancer the wrong target?
FDA · non-small cell lung cancer · 5 min
Dr. Sarah MitchellAbivax colitis drug hits goal, but cancer cases rattle investors
colitis · 5 min
Dr. Sarah MitchellSupreme Court sides with generic drug maker in icosapent ethyl patent case
U.S. Supreme Court · severe hypertriglyceridemia · 6 min
Dr. Sarah MitchellExplore intelligence